Clinical trial: comparison of the gastrointestinal safety of lumiracoxib with traditional nonselective nonsteroidal anti-inflammatory drugs early after the initiation of treatment - findings from the Therapeutic Arthritis Research and Gastrointestinal Event Trial

May 2008

Author(s): Hawkey CJ, Weinstein WM, Stricker K, Murphy V, Richard D, Krammer G, et al

‚ÄčAlimentary Pharmacology & Therapeutics. 2008 May;27(9):838-45.

NIHR Acknowledged: Yes

Photo Name Bio
professor-christopher-hawkey Professor Christopher Hawkey Christopher Hawkey is Professor of Gastroenterology at the Nottingham Digestive Diseases Centre. His main interests are in the field of non-steroid anti-inflammatory drugs and inflammatory bowel disease. In both areas his approach is to try to identify…